Evidence map›Paper›PMID 23790754›Full record

ArticleNeuron2013

Transient inhibition of TrkB kinase after status epilepticus prevents development of temporal lobe epilepsy.

Gumei Liu, Bin Gu, Xiao-Ping He, Rasesh B Joshi, Harold D Wackerle, Ramona Marie Rodriguiz, William C Wetsel, James O McNamara

Abstract read
In one paragraph

Article in Neuron, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Low-dose 7,8-Dihydroxyflavone Administration After Status Epilepticus Prevents Epilepsy Development.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2022
    Article
  12. Seizure-induced strengthening of a recurrent excitatory circuit in the dentate gyrus is proconvulsant.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Selected Molecular Targets for Antiepileptogenesis.International journal of molecular sciences · 2021
    Review
  18. Review
  19. Review
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gumei LiuDepartment of Neurobiology, Duke University Medical Center, Durham, NC 27710, USA.
Bin Gu
Xiao-Ping He
Rasesh B Joshi
Harold D Wackerle
Ramona Marie Rodriguiz
William C Wetsel
James O McNamara

Funding

Neurotrophins and EpileptogenesisR01NS056217 · NINDS · DUKE UNIVERSITY · PI MCNAMARA, JAMES O. · 2006 to 2023
$6.7M
Basic Predoctoral Training in NeuroscienceT32GM008441 · NIGMS · DUKE UNIVERSITY · PI MCNAMARA, JAMES O. · 1992 to 2017
$4.4M
Mechanisms of Limbic EpileptogenesisR01NS060728 · NINDS · DUKE UNIVERSITY · PI MCNAMARA, JAMES O. · 2009 to 2010
$780k
Intramural NIH HHSNIGMS NIH HHS T32 GM008441NINDS NIH HHS NS060728NINDS NIH HHS NS56217NINDS NIH HHS R01 NS056217NINDS NIH HHS R01 NS060728
6 · The paper itself

Abstract

Temporal lobe epilepsy is the most common and often devastating form of human epilepsy. The molecular mechanism underlying the development of temporal lobe epilepsy remains largely unknown. Emerging evidence suggests that activation of the BDNF receptor TrkB promotes epileptogenesis caused by status epilepticus. We investigated a mouse model in which a brief episode of status epilepticus results in chronic recurrent seizures, anxiety-like behavior, and destruction of hippocampal neurons. We used a chemical-genetic approach to selectively inhibit activation of TrkB. We demonstrate that inhibition of TrkB commencing after status epilepticus and continued for 2 weeks prevents recurrent seizures, ameliorates anxiety-like behavior, and limits loss of hippocampal neurons when tested weeks to months later. That transient inhibition commencing after status epilepticus can prevent these long-lasting devastating consequences establishes TrkB signaling as an attractive target for developing preventive treatments of epilepsy in humans.

Indexed as

AmygdalaAnimalsBehavior, AnimalDisease Models, AnimalElectroencephalographyEpilepsy, Temporal LobeHippocampusKainic AcidMiceMotor ActivityNeuronsReceptor, trkBSignal TransductionStatus EpilepticusKainic AcidReceptor, trkB

Identifiers

PMID23790754
PMCPMC3744583

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.